Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: A north central cancer treatment group (NCCTG) phase II clinical trial

Steven R. Alberts, Vera J. Suman, Henry C. Pitot, John K. Camoriano, Joseph Rubin

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: A north central cancer treatment group (NCCTG) phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences